Merck stock pops on Deutsche Bank upgrade — what to watch ahead of ASCO GU
Merck shares climbed 1.8% to $121.41 in after-hours trading Friday after Deutsche Bank upgraded the stock and raised its price target. The move comes ahead of key cancer study results set for release at the ASCO Genitourinary Cancers Symposium later this month. Merck’s chief marketing officer sold 10,000 shares on Feb. 12. U.S. markets are closed Monday for Washington’s Birthday; trading resumes Tuesday.